The effects of d-amphetamine, methylphenidate, sydnocarb, and caffeine on prepulse inhibition of the startle reflex in DBA/2 mice

Psychopharmacology

Volumn 211, Issue 3, 2010, Pages 325-336

  Flood, Dorothy G ^a   Zuvich, Eva ^a   Marino, Michael J ^a,b   Gasior, MacIej ^a  

^a CEPHALON INC   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Acoustic startle reflex; Baseline PPI; Dopamine; Indirect agonists; Noise exposure; Psychostimulants; Schizophrenia; Sensorimotor gating; Translational model

Indexed keywords

CAFFEINE; DEXAMPHETAMINE; METHYLPHENIDATE; SYDNOCARB; CENTRAL STIMULANT AGENT; SYDNONE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DBA 2 MOUSE; MALE; MOUSE; NOISE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; SENSORY GATING; STARTLE REFLEX; ANIMAL; DBA MOUSE; DOSE RESPONSE; DRUG EFFECTS; PHYSIOLOGY;

ANIMALS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHYLPHENIDATE; MICE; MICE, INBRED DBA; NOISE; SENSORY GATING; SYDNONES;

EID: 77955468729     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1901-0     Document Type: Article

References (44)

1. VP Bakshi MA Geyer N Taaid NR Swerdlow 1995 A comparison of the effects of amphetamine, strychnine and caffeine on prepulse inhibition and latent inhibition Behav Pharmacol 6 801 809 10.1097/00008877-199512000-00005 1:CAS:528:DyaK28XhtVSgtbw%3D 11224383
2. P Bitsios SG Giakoumaki S Frangou 2005 The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values Psychopharmacology 182 144 152 10.1007/s00213-005-0056-x 1:CAS:528: DC%2BD2MXhtVOitb7F 16010540 (Pubitemid 41400871)
3. DL Braff MA Geyer NR Swerdlow 2001 Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies Psychopharmacology 156 234 258 10.1007/s002130100810 1:CAS:528: DC%2BD3MXmtlCqtbY%3D 11549226 (Pubitemid 32705488)
4. G De Sarro A De Sarro ED Di Paola R Bertorelli 1999 Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice Eur J Pharmacol 371 137 145 10.1016/S0014-2999(99)00132-6 10357250 (Pubitemid 29216995)
5. G Drolet K Proulx D Pearson J Rochford CF Deschepper 2002 Comparisons of behavioral and neurochemical characteristics between WKY, WKHA, and Wistar rat strains Neuropsychopharmacology 27 400 409 10.1016/S0893-133X(02)00303-2 1:CAS:528:DC%2BD38XmvVWqs74%3D 12225697 (Pubitemid 35253787)
6. DG Flood M Gasior MJ Marino 2007 Variables affecting prepulse inhibition of the startle reflex and the response to antipsychotics in DBA/2NCrl mice Psychopharmacology 195 203 211 10.1007/s00213-007-0894-9 1:CAS:528: DC%2BD2sXht1CltbrN 17668187 (Pubitemid 350045846)
7. DG Flood M Choinski MJ Marino M Gasior 2009 Mood stabilizers increase prepulse inhibition in DBA/2NCrl mice Psychopharmacology 205 369 377 10.1007/s00213-009-1547-y 1:CAS:528:DC%2BD1MXltFymtLo%3D 19404613
8. BE Garrett RR Griffiths 1997 The role of dopamine in the behavioral effects of caffeine in animals and humans Pharmacol Biochem Behav 57 533 541 10.1016/S0091-3057(96)00435-2 1:CAS:528:DyaK2sXkt1yhsr0%3D 9218278 (Pubitemid 27296765)
9. MA Geyer K Krebs-Thomson DL Braff NR Swerdlow 2001 Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology 156 117 154 10.1007/s002130100811 1:CAS:528:DC%2BD3MXmtlCqtLY%3D 11549216 (Pubitemid 32702206)
10. MA Geyer KL McIlwain R Paylor 2002 Mouse genetic models for prepulse inhibition: an early review Molec Psychiatry 7 1039 1053 10.1038/sj.mp.4001159 1:CAS:528:DC%2BD38XptlyksLk%3D (Pubitemid 36044262)
11. SM Grauer VL Pulito RL Navarra MP Kelly C Kelley R Graf B Langen S Logue J Brennan L Jiang E Charych U Egerland F Liu KL Marquis M Malamas T Hage TA Comery NJ Brandon 2009 Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia J Pharmacol Exp Ther 331 574 590 10.1124/jpet.109.155994 1:CAS:528: DC%2BD1MXhtlKnu73O 19661377
12. JA Gruner DG Flood JR Mathiasen LD Aimone MJ Marino M Gasior 2008 Biochemical, pharmacological, and behavioral characterization of the dopaminergic stimulant sydnocarb in rats Neurosci Abstr 34 285
13. TB Halene SJ Siegel 2008 Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2- imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle J Pharmacol Exp Ther 326 230 239 10.1124/jpet.108.138586 1:CAS:528:DC%2BD1cXotlyltro%3D 18420599 (Pubitemid 351872113)
14. SJ Kanes J Tokarczyk SJ Siegel W Bilker T Abel MP Kelly 2007 Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity Neuroscience 144 239 246 10.1016/j.neuroscience.2006.09.026 1:CAS:528: DC%2BD28Xht12qsLvK 17081698 (Pubitemid 44839057)
15. MP Kelly C Isiegas Y-F Cheung J Tokarczyk X Yang MF Esposito DA Rapoport SA Fabian SJ Siegel G Wand MD Houslay SJ Kanes T Abel 2007 Constitutive activation of Gαs within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP Neuropsychopharmacology 32 577 588 10.1038/sj.npp.1301099 1:CAS:528:DC%2BD2sXhslWhurs%3D 16738544
16. GG Kinney LO Wilkinson KL Saywell MD Tricklebank 1999 Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity J Neurosci 19 5644 5653 1:CAS:528:DyaK1MXktlyjsrc%3D 10377370
17. R Kuczenski DS Segal 1997 Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine J Neurochem 68 2032 2037 1:CAS:528:DyaK2sXivVSjsb4%3D 9109529 (Pubitemid 27176139)
18. J McCaughran Jr E Mahjubi E Decena R Hitzemann 1997 Genetics, haloperidol-induced catalepsy and haloperidol-induced changes in acoustic startle and prepulse inhibition Psychopharmacology 134 131 139 10.1007/s002130050434 1:CAS:528:DyaK2sXns1Kkt70%3D 9399376 (Pubitemid 27522568)
19. B Olivier C Leahy T Mullen R Paylor VE Groppi Z Sarnyai D Brunner 2001 The DBA/2 J strain and prepulse inhibition of startle: a model system to test antipsychotics? Psychopharmacology 156 284 290 10.1007/s002130100828 1:CAS:528:DC%2BD3MXmtlCqurw%3D 11549230 (Pubitemid 32702219)
20. R Paylor JN Crawley 1997 Inbred strain differences in prepulse inhibition of the mouse startle response Psychopharmacology 132 169 180 10.1007/s002130050333 1:CAS:528:DyaK2sXlt1Wntbs%3D 9266614 (Pubitemid 27338992)
21. W Perry A Minassian D Feifel DL Braff 2001 Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania Biol Psychiatry 50 418 424 10.1016/S0006-3223(01)01184-2 1:STN:280:DC%2BD3MrhvFSkuw%3D%3D 11566158 (Pubitemid 32885591)
22. CF Plappert S Kuhn H-U Schnitzler PKD Pilz 2006 Experience increases the prepulse inhibition of the acoustic startle response in mice Behav Neurosci 120 16 23 10.1037/0735-7044.120.1.16 16492113 (Pubitemid 43345103)
23. S Puglisi-Allegra S Cabib 1997 Psychopharmacology of dopamine: the contribution of comparative studies in inbred strains of mice Prog Neurobiol 51 637 661 10.1016/S0301-0082(97)00008-7 1:CAS:528:DyaK2sXjvFehs7k%3D 9175160 (Pubitemid 27244540)
24. RJ Ralph SB Caine 2005 Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice J Pharmacol Exp Ther 312 733 741 10.1124/jpet.104.074468 1:CAS:528:DC%2BD2MXhsVCnt78%3D 15494551 (Pubitemid 40189573)
25. RJ Ralph SB Caine 2007 Effects of selective dopamine D1-like and D2-like agonists on prepulse inhibition of startle in inbred C3H/HeJ, SPRET/EiJ, and CAST/EiJ mice Psychopharmacology 191 731 739 10.1007/s00213-006-0511-3 1:CAS:528:DC%2BD2sXitlCqtb8%3D 17019570 (Pubitemid 46355880)
26. TW Robbins BJ Sahakian 1979 "Paradoxical" effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology Neuropharmacology 18 931 950 10.1016/0028-3908(79) 90157-6 1:CAS:528:DyaL3cXhsVSlurs%3D 43484 (Pubitemid 10117383)
27. CJ Schmidt DS Chapin J Cianfrogna ML Corman M Hajos JF Harms WE Hoffman LA Lebel SA McCarthy FR Nelson C Proulx-LaFrance MJ Majchrzak AD Ramirez K Schmidt PA Seymour JA Siuciak FD Tingley III RD Williams PR Verhoest FS Menniti 2008 Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia J Pharmacol Exp Ther 325 681 690 10.1124/jpet.107.132910 1:CAS:528:DC%2BD1cXlsVOjtL8%3D 18287214 (Pubitemid 351574819)
28. P Singer J Feldon BK Yee 2009 Are DBA/2 mice associated with schizophrenia-like endophenotypes? A behavioural contrast with C57BL/6 mice Psychopharmacology 206 677 698 10.1007/s00213-009-1568-6 1:CAS:528: DC%2BD1MXms1alu78%3D 19484222
29. MV Solanto 1998 Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration Behav Brain Res 94 127 152 10.1016/S0166-4328(97)00175-7 1:CAS:528: DyaK1cXjs1arsL8%3D 9708845 (Pubitemid 28352470)
30. NR Swerdlow DL Braff N Taaid MA Geyer 1994 Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients Arch Gen Psychiatry 51 139 154 1:STN:280:DyaK2c7isl2gsQ%3D%3D 8297213
31. NR Swerdlow A Eastvold T Gerbranda KM Uyan P Hartman Q Doan P Auerbach 2000 Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects: impact of caffeine intake and withdrawal Psychopharmacology 151 368 378 10.1007/s002130000490 1:CAS:528:DC%2BD3cXntVaqurs%3D 11026744
32. NR Swerdlow A Eastvold B Karban Y Ploum N Stephany MA Geyer K Cadenhead P Auerbach 2002 Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies Psychopharmacology 161 189 201 10.1007/s00213-002-1040-3 1:CAS:528:DC%2BD38Xlt1egtrc%3D 11981599 (Pubitemid 34492664)
33. NR Swerdlow N Stephany JM Shoemaker L Ross LC Wasserman J Talledo PP Auerbach 2002 Effects of amantadine and bromocriptine on startle and sensorimotor gating: parametric studies and cross-species comparisons Psychopharmacology 164 82 92 10.1007/s00213-002-1172-5 1:CAS:528: DC%2BD38Xns1Ogtr4%3D 12373422 (Pubitemid 35203845)
34. NR Swerdlow J Talledo AN Sutherland D Nagy JM Shoemaker 2006 Antipsychotic effects on prepulse inhibition in normal 'low gating' humans and rats Neuropsychopharmacology 31 2011 2021 10.1038/sj.npp.1301043 1:CAS:528:DC%2BD28XotFKlu7g%3D 16482083
35. NR Swerdlow JM Shoemaker MJ Bongiovanni AC Neary LS Tochen RL Saint Marie 2007 Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration Pharmacol Biochem Behav 87 1 10 10.1016/j.pbb.2007.03.014 1:CAS:528:DC%2BD2sXmtlSmsrw%3D 17475315 (Pubitemid 46855814)
36. NR Swerdlow M Weber Y Qu GA Light DL Braff 2008 Realistic expectations of prepulse inhibition in translational models for schizophrenia research Psychopharmacology 199 331 388 10.1007/s00213-008-1072-4 1:CAS:528: DC%2BD1cXotVyrtrk%3D 18568339
37. JA Talledo ANS Owens T Schortinghuis NR Swerdlow 2009 Amphetamine effects on startle gating in normal women and female rats Psychopharmacology 204 165 175 10.1007/s00213-008-1446-7 1:CAS:528:DC%2BD1MXlvFynsA%3D%3D 19148623
38. JG Turner JF Willott 1998 Exposure to an augmented acoustic environment alters auditory function in hearing-impaired DBA/2J mice Hearing Res 118 101 113 10.1016/S0378-5955(98)00024-0 1:STN:280:DyaK1c3mslWjsA%3D%3D (Pubitemid 28212333)
39. GB Varty N Walters M Cohen-Williams GJ Carey 2001 Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains Eur J Pharmacol 424 27 36 10.1016/S0014-2999(01) 01115-3 1:CAS:528:DC%2BD3MXltlOhtrY%3D 11470257 (Pubitemid 32695551)
40. R Ventura A Alcaro S Cabib D Conversi L Mandolesi S Puglisi-Allegra 2004 Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion Neuropsychopharmacology 29 72 80 10.1038/sj.npp.1300300 1:CAS:528: DC%2BD3sXhtVSqs7bO 12968132 (Pubitemid 38068015)
41. FX Vollenweider M Barro PA Csomor J Feldon 2006 Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels Biol Psychiatry 60 597 603 10.1016/j.biopsych.2006.03.058 1:CAS:528:DC%2BD28XpvFelsbg%3D 16997001 (Pubitemid 44402382)
42. M Weber M Breier D Ko N Thangaraj DE Marzan NR Swerdlow 2009 Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine Psychopharmacology 203 723 735 10.1007/s00213-008-1419-x 1:CAS:528: DC%2BD1cXhsVOgtbnN 19066855
43. JM Witkin N Savtchenko M Mashkovsky M Beekman P Munzar M Gasior SR Goldberg JT Ungard J Kim T Shippenberg V Chefer 1999 Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine J Pharmacol Exp Ther 288 1298 1310 1:CAS:528: DyaK1MXhs1Kis7c%3D 10027871
44. S Yamada M Harano N Annoh K Nakamura M Tanaka 1999 Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats Biol Psychiatry 46 832 838 10.1016/S0006-3223(98)00356-4 1:CAS:528:DyaK1MXmtVOqtbo%3D 10494453 (Pubitemid 29460911)